"Paclitaxel or no Paclitaxel in second-line, that's the question" in ovarian cancer patients who relapse after a prolonged platinum-free interval

J.B Vermorken, R. Huijskens, R.E.N. van Rijswijk, K. Hoekman, RHM Verheijen, P. Kenemans, H.M. Pinedo

Research output: Contribution to conferenceAbstractOther research output

Original languageEnglish
Publication statusPublished - 1994
Event8th NCI-EORTC Symposium on New Drugs in Cancer Therapy - Amsterdam, Netherlands
Duration: 23 Sept 1994 → …

Conference

Conference8th NCI-EORTC Symposium on New Drugs in Cancer Therapy
Country/TerritoryNetherlands
CityAmsterdam
Period23/09/94 → …

Cite this